X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1464) 1464
Publication (163) 163
Book Review (45) 45
Newsletter (17) 17
Book Chapter (11) 11
Magazine Article (3) 3
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
azithromycin (1110) 1110
humans (843) 843
index medicus (726) 726
pharmacology & pharmacy (417) 417
female (403) 403
male (401) 401
antibiotics (368) 368
anti-bacterial agents - therapeutic use (311) 311
anti-bacterial agents - pharmacology (288) 288
clarithromycin (262) 262
azithromycin - therapeutic use (256) 256
animals (251) 251
azithromycin - pharmacology (245) 245
erythromycin (243) 243
adult (242) 242
microbiology (225) 225
drug interactions (213) 213
infectious diseases (195) 195
macrolides (174) 174
middle aged (172) 172
anti-bacterial agents - administration & dosage (156) 156
research (154) 154
aged (151) 151
azithromycin - administration & dosage (147) 147
health aspects (145) 145
analysis (142) 142
infections (136) 136
microbial sensitivity tests (135) 135
pharmacokinetics (134) 134
infection (131) 131
anti-bacterial agents - adverse effects (129) 129
drug therapy (123) 123
macrolide antibiotics (123) 123
treatment outcome (117) 117
immunology (113) 113
bacteria (108) 108
therapy (108) 108
in-vitro (106) 106
anti-bacterial agents - pharmacokinetics (104) 104
adolescent (99) 99
respiratory system (99) 99
risk factors (99) 99
azithromycin - adverse effects (95) 95
drugs (95) 95
research article (95) 95
mice (94) 94
care and treatment (93) 93
antimicrobial agents (89) 89
inflammation (89) 89
azithromycin - pharmacokinetics (87) 87
dosage and administration (86) 86
child (85) 85
medicine (83) 83
drug therapy, combination (82) 82
drug resistance (80) 80
pseudomonas-aeruginosa (80) 80
cystic fibrosis (78) 78
studies (78) 78
anti-bacterial agents - chemistry (77) 77
pneumonia (77) 77
medicine, general & internal (76) 76
children (75) 75
prevention (75) 75
time factors (73) 73
internal medicine (72) 72
macrolide (71) 71
efficacy (70) 70
erythromycin - pharmacology (70) 70
article (69) 69
resistance (69) 69
medicine & public health (68) 68
pharmacology/toxicology (68) 68
clinical trials (64) 64
clarithromycin - pharmacology (63) 63
abridged index medicus (62) 62
administration, oral (62) 62
double-blind (62) 62
drug-interactions (62) 62
multidisciplinary sciences (62) 62
roxithromycin (62) 62
child, preschool (61) 61
azithromycin - chemistry (60) 60
ciprofloxacin (60) 60
dose-response relationship, drug (60) 60
double-blind method (60) 60
mortality (60) 60
clarithromycin - therapeutic use (59) 59
drug resistance in microorganisms (58) 58
drug resistance, bacterial (57) 57
antibacterial agents (56) 56
antimicrobial resistance (56) 56
disease (56) 56
pharmacology (56) 56
young adult (56) 56
infant (55) 55
macrolides - pharmacology (55) 55
risk (55) 55
usage (55) 55
pediatrics (54) 54
cystic-fibrosis (51) 51
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1471) 1471
French (5) 5
Spanish (4) 4
German (3) 3
Japanese (2) 2
Russian (2) 2
Bulgarian (1) 1
Chinese (1) 1
Danish (1) 1
Dutch (1) 1
Hebrew (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Annals of Pharmacotherapy, ISSN 1060-0280, 04/2007, Volume 41, Issue 4, pp. 674 - 680
The assessment of causation for a potential drug interaction requires thoughtful consideration of the properties of both the object and precipitant drugs,... 
Probabity | Drug interactions | Causation | drug interactions | causation | probability | ALGORITHM | PHARMACOLOGY & PHARMACY | AZITHROMYCIN | CYCLOSPORINE | Drug Interactions | Drug Administration Schedule | Time Factors | Humans | Probability | Surveys and Questionnaires | Causality | Pharmacokinetics
Journal Article
Journal Article
Current Opinion in Pulmonary Medicine, ISSN 1070-5287, 11/2015, Volume 21, Issue 6, pp. 617 - 625
Journal Article
Journal of Chromatography B, ISSN 1570-0232, 01/2019, Volume 1104, pp. 1 - 10
Micellar mobile phase was utilized for the separation and quantification of two antimicrobial mixtures with some analgesics that were found to augment their... 
Cefotaxime | Synergism | Naproxen | Ibuprofen | Azithromycin | Diclofenac | CHEMISTRY, ANALYTICAL | ANTIBIOTICS | BIOCHEMICAL RESEARCH METHODS | HPLC-DETERMINATION | Phosphates | Complications and side effects | Phosphoric acid | Pharmacy | Drug interactions | Liver | Drugstores | Nitriles | Nonsteroidal anti-inflammatory drugs | Chromatography
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 1/2011, Volume 50, Issue 1, pp. 25 - 39
Etravirine (formerly TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) with activity against wild-type and NNRTI-resistant strains of HIV-1.... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Drug-interactions | Ribavirin, drug interactions | Antiepileptic-drugs, drug interactions | Simvastatin, drug interactions | Voriconazole, drug interactions | Dexamethasone, drug interactions | Fibric-acid-derivatives, drug interactions | Rifampicin, drug interactions | Opioid-analgesics, drug interactions | Antidepressants, drug interactions | Atorvastatin, drug interactions | Antiretrovirals, drug interactions | Anti-infectives, drug interactions | Histamine-H2-receptor-antagonists, drug interactions | Diazepam, drug interactions | Ketoconazole, drug interactions | Fluconazole, drug interactions | Hypericum, drug interactions | HMG-CoA-reductase-inhibitors, drug interactions | Oral-contraceptives, drug interactions | Sildenafil, drug interactions | Omeprazole, drug interactions | Buprenorphine, drug interactions | Rosuvastatin, drug interactions | Non-nucleoside-reverse-transcriptase-inhibitors, drug interactions | Type-5-cyclic-nucleotide- phosphodiesterase-inhibitors, drug interactions | Corticosteroids, drug interactions | Paroxetine, drug interactions | Fluoxetine, drug interactions | Rifapentine, drug interactions | Ethinylestradiolnorethisterone, drug interactions | Ranitidine, drug interactions | Etravirine, drug interactions | Antifungals, drug interactions | Digoxin, drug interactions | Warfarin, drug interactions | Methadone, drug interactions | Fluvastatin, drug interactions | Rifabutin, drug interactions | Sertraline, drug interactions | Azithromycin, drug interactions | Pharmacokinetics | Calcineurin-inhibitors, drug interactions | Itraconazole, drug interactions | Proton-pump-inhibitors, drug interactions | Clarithromycin, drug interactions | TRANSCRIPTASE INHIBITOR ETRAVIRINE | METABOLISM | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | HIV-NEGATIVE VOLUNTEERS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HUMAN LIVER | PLACEBO-CONTROLLED TRIAL | 2 DIFFERENT FORMULATIONS | CLINICAL PHARMACOKINETICS | Reverse Transcriptase Inhibitors - adverse effects | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Drug-Related Side Effects and Adverse Reactions | Humans | Pyridazines - pharmacokinetics | Drug Therapy, Combination | Pyridazines - adverse effects | Etravirine | Drug interactions | Physiological aspects | Dosage and administration | Research | Properties | Drug therapy | HIV infection
Journal Article
BMJ Open, ISSN 2044-6055, 07/2013, Volume 3, Issue 7, pp. e002857 - e002857
Objective Clarithromycin strongly inhibits enzyme cytochrome P450 3A4, preventing the metabolism of some other drugs, while azithromycin is a weak inhibitor.... 
CLARITHROMYCIN | MEDICINE, GENERAL & INTERNAL | Public Health | Clinical Pharmacology | Preventive Medicine | 3A4 | RISK | AZITHROMYCIN | RHABDOMYOLYSIS
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 3/2008, Volume 64, Issue 3, pp. 303 - 309
Journal Article
Lipids in Health and Disease, ISSN 1476-511X, 10/2015, Volume 14, Issue 1, p. 131
Background: Clarithromycin, known as a potent inhibitor of the cytochrome P450 isoenzyme CYP3A, may increase the plasma concentration of statins metabolized by... 
Clarithromycin | HMG-CoA reductase inhibitors | Electronic health records | Drug interactions | Cohort studies | BIOCHEMISTRY & MOLECULAR BIOLOGY | AZITHROMYCIN | INDUCTION | INDUCERS | CYTOCHROME-P450 3A4 | RHABDOMYOLYSIS | ATORVASTATIN | NUTRITION & DIETETICS | CYP3A4 INHIBITORS | CONCOMITANT USE | SIMVASTATIN | ADMINISTRATIVE CLAIMS | Dyslipidemias - mortality | Simvastatin - therapeutic use | Rosuvastatin Calcium - therapeutic use | Simvastatin - adverse effects | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Rosuvastatin Calcium - adverse effects | Male | Risk | Drug Interactions | Cardiovascular Diseases - mortality | Pravastatin - adverse effects | Adult | Female | Retrospective Studies | Pravastatin - therapeutic use | Atorvastatin Calcium - adverse effects | Atorvastatin Calcium - therapeutic use | Dyslipidemias - drug therapy | Clarithromycin - adverse effects | Clarithromycin - therapeutic use | Hospitalization | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Aged | Cytochrome P-450 CYP3A Inhibitors - adverse effects | Cytochrome P-450 CYP3A Inhibitors - therapeutic use | Drugs | Medical records | Complications and side effects | Usage | Diabetes | Studies | Data analysis | Hospitals | Antibiotics | Mortality | Data collection | Cardiovascular disease | Population | Prescriptions | Statins
Journal Article
Nature, ISSN 0028-0836, 07/2018, Volume 559, Issue 7713, pp. 259 - 263
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2006, Volume 54, Issue 4, pp. 676 - 684
Although there are thousands of drug interactions (DIs) listed in computers and manuals, only about 10% are clinically significant. Equally disturbing is these... 
POTENTIAL INTERACTION | CLARITHROMYCIN | TORSADES-DE-POINTES | WARFARIN | RISK | AZITHROMYCIN | ATORVASTATIN | DERMATOLOGY | Humans | Dermatologic Agents | Drug Interactions | Complications and side effects | Drug interactions
Journal Article